Argitalpenak (82) LAURA MORENO GUTIÉRREZ argitalpenak

2023

  1. Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)

    Frontiers in Pharmacology

  2. Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

    Frontiers in Pharmacology, Vol. 14

  3. The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit

    Biomedicine and Pharmacotherapy, Vol. 164

2021

  1. Article serum micrornas as biomarkers of sepsis and resuscitation

    Applied Sciences (Switzerland), Vol. 11, Núm. 23

  2. Extracellular Vesicles and Alveolar Epithelial-Capillary Barrier Disruption in Acute Respiratory Distress Syndrome: Pathophysiological Role and Therapeutic Potential

    Frontiers in Physiology, Vol. 12

  3. Interleukin-6 and intrapulmonary shunt

    European Respiratory Journal

  4. Oxygen-sensitivity and pulmonary selectivity of vasodilators as potential drugs for pulmonary hypertension

    Antioxidants, Vol. 10, Núm. 2, pp. 1-14

  5. Restoration of vitamin d levels improves endothelial function and increases task-like k+ currents in pulmonary arterial hypertension associated with vitamin d deficiency

    Biomolecules, Vol. 11, Núm. 6

2020

  1. Liver–lung interactions in acute respiratory distress syndrome

    Intensive Care Medicine Experimental , Vol. 8

  2. Na+ controls hypoxic signalling by the mitochondrial respiratory chain

    Nature, Vol. 586, Núm. 7828, pp. 287-291

  3. Total, bioavailable, and free vitamin D levels and their prognostic value in pulmonary arterial hypertension

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  4. Uncovered Contribution of Kv7 Channels to Pulmonary Vascular Tone in Pulmonary Arterial Hypertension

    Hypertension, Vol. 76, Núm. 4, pp. 1134-1146

  5. Vitamin D deficiency downregulates TASK-1 channels and induces pulmonary vascular dysfunction

    American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 319, Núm. 4, pp. L627-L640

2019

  1. Activation of Kv7 channels as a novel mechanism for NO/cGMP-induced pulmonary vasodilation

    British Journal of Pharmacology, Vol. 176, Núm. 13, pp. 2131-2145

  2. Ceramide and regulation of vascular tone

    International Journal of Molecular Sciences, Vol. 20, Núm. 2

  3. Elevated pulmonary arterial pressure in Zucker diabetic fatty rats

    PLoS ONE, Vol. 14, Núm. 1

  4. Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia

    PLoS ONE, Vol. 14, Núm. 3

  5. Fas activation alters tight junction proteins in acute lung injury

    Thorax, Vol. 74, Núm. 1, pp. 69-82

  6. Preventing bronchopulmonary dysplasia: new tools for an old challenge

    Pediatric Research, Vol. 85, Núm. 4, pp. 432-441

  7. Reactive oxygen species as mediators of oxygen signaling during fetal-to-neonatal circulatory transition

    Free Radical Biology and Medicine, Vol. 142, pp. 82-96